Hybio Pharmaceutical Co., Ltd. (SHE:300199)

Hybio Pharmaceutical Statistics

Total Valuation

SHE:300199 has a market cap or net worth of CNY 23.77 billion. The enterprise value is 24.93 billion.

Market Cap	23.77B
Enterprise Value	24.93B

Important Dates

The last earnings date was Friday, August 22, 2025.

Earnings Date	Aug 22, 2025
Ex-Dividend Date	n/a

Share Statistics

SHE:300199 has 883.24 million shares outstanding. The number of shares has decreased by -17.64% in one year.

Current Share Class	883.24M
Shares Outstanding	883.24M
Shares Change (YoY)	-17.64%
Shares Change (QoQ)	+8.20%
Owned by Insiders (%)	24.70%
Owned by Institutions (%)	3.62%
Float	640.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	26.89
PB Ratio	32.07
P/TBV Ratio	53.52
P/FCF Ratio	171.59
P/OCF Ratio	82.28
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 78.68, with an EV/FCF ratio of 179.95.

EV / Earnings	-1,398.23
EV / Sales	28.20
EV / EBITDA	78.68
EV / EBIT	146.40
EV / FCF	179.95

Financial Position

The company has a current ratio of 0.48, with a Debt / Equity ratio of 2.04.

Current Ratio	0.48
Quick Ratio	0.31
Debt / Equity	2.04
Debt / EBITDA	4.78
Debt / FCF	10.93
Interest Coverage	1.64

Financial Efficiency

Return on equity (ROE) is -3.23% and return on invested capital (ROIC) is 4.42%.

Return on Equity (ROE)	-3.23%
Return on Assets (ROA)	3.32%
Return on Invested Capital (ROIC)	4.42%
Return on Capital Employed (ROCE)	9.98%
Revenue Per Employee	854,030
Profits Per Employee	-17,224
Employee Count	1,035
Asset Turnover	0.28
Inventory Turnover	1.71

Taxes

In the past 12 months, SHE:300199 has paid 25.97 million in taxes.

Income Tax	25.97M
Effective Tax Rate	1,901.03%

Stock Price Statistics

The stock price has increased by +185.46% in the last 52 weeks. The beta is 0.79, so SHE:300199's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+185.46%
50-Day Moving Average	21.34
200-Day Moving Average	15.35
Relative Strength Index (RSI)	54.98
Average Volume (20 Days)	147,909,152

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:300199 had revenue of CNY 883.92 million and -17.83 million in losses. Loss per share was -0.02.

Revenue	883.92M
Gross Profit	494.00M
Operating Income	170.26M
Pretax Income	1.37M
Net Income	-17.83M
EBITDA	316.84M
EBIT	170.26M
Loss Per Share	-0.02

Balance Sheet

The company has 373.36 million in cash and 1.51 billion in debt, giving a net cash position of -1.14 billion or -1.29 per share.

Cash & Cash Equivalents	373.36M
Total Debt	1.51B
Net Cash	-1.14B
Net Cash Per Share	-1.29
Equity (Book Value)	741.24M
Book Value Per Share	0.77
Working Capital	-866.54M

Cash Flow

In the last 12 months, operating cash flow was 288.87 million and capital expenditures -150.35 million, giving a free cash flow of 138.51 million.

Operating Cash Flow	288.87M
Capital Expenditures	-150.35M
Free Cash Flow	138.51M
FCF Per Share	0.16

Margins

Gross margin is 55.89%, with operating and profit margins of 19.26% and -2.02%.

Gross Margin	55.89%
Operating Margin	19.26%
Pretax Margin	0.15%
Profit Margin	-2.02%
EBITDA Margin	35.84%
EBIT Margin	19.26%
FCF Margin	15.67%

Dividends & Yields

SHE:300199 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	17.64%
Shareholder Yield	n/a
Earnings Yield	-0.08%
FCF Yield	0.58%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 14, 2015. It was a forward split with a ratio of 2.

Last Split Date	Apr 14, 2015
Split Type	Forward
Split Ratio	2

Scores

Altman Z-Score	n/a
Piotroski F-Score	7